Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.55 USD | -3.61% | +1.99% | -16.84% |
May. 10 | Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating | MT |
May. 08 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Financials (USD)
Sales 2024 * | 316M | Sales 2025 * | 406M | Capitalization | 1.16B |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -1M | EV / Sales 2024 * | 3.37 x |
Net cash position 2024 * | 93.72M | Net cash position 2025 * | 88.72M | EV / Sales 2025 * | 2.63 x |
P/E ratio 2024 * |
-18.5
x | P/E ratio 2025 * |
470
x | Employees | 278 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.51% |
Latest transcript on Mirum Pharmaceuticals, Inc.
1 day | -3.61% | ||
1 week | +1.99% | ||
Current month | -2.23% | ||
1 month | +2.21% | ||
3 months | -11.72% | ||
6 months | -24.11% | ||
Current year | -16.84% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 45 | 18-05-06 | |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Peter Radovich
PSD | President | 46 | 20-04-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Walbert
BRD | Director/Board Member | 57 | 23-04-04 |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Patrick Heron
BRD | Director/Board Member | 53 | 18-11-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.02% | 1,487 M€ | +8.80% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 24.55 | -3.61% | 319,055 |
24-05-23 | 25.47 | -2.86% | 502,209 |
24-05-22 | 26.22 | +1.67% | 309,152 |
24-05-21 | 25.79 | +1.94% | 344,702 |
24-05-20 | 25.3 | +5.11% | 377,645 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.84% | 1.16B | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- MIRM Stock